Monica Loi

1.5k total citations
31 papers, 1.1k citations indexed

About

Monica Loi is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Monica Loi has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 14 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Monica Loi's work include Neuroblastoma Research and Treatments (15 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Lung Cancer Research Studies (5 papers). Monica Loi is often cited by papers focused on Neuroblastoma Research and Treatments (15 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Lung Cancer Research Studies (5 papers). Monica Loi collaborates with scholars based in Italy, Switzerland and United States. Monica Loi's co-authors include Mirco Ponzoni, Fabio Pastorino, Gabriella Pagnan, Daniela Di Paolo, Chiara Brignole, Patrizia Perri, Michele Cilli, Doménico Ribatti, Pamela Becherini and Laura Emionite and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Monica Loi

30 papers receiving 1.1k citations

Peers

Monica Loi

IMMUN

ONCOL

EPIDE

BIOMA

Gabriella Pagnan Italy

Zhao Yang China

Padma Shastry India

Mohammad Doroudian Iran

José L. Alonso-Lebrero Spain

Xinggang Mao China

Kyung Hee Noh South Korea

Xiancheng Chen China

Afshin Namdar Canada

Lan Ma China

Gabriella Pagnan Italy

Monica Loi

1.2k ×2.2

255 ×1.0

IMMUN

477 ×2.5

ONCOL

63 ×0.4

EPIDE

310 ×1.8

BIOMA

Citations per year, relative to Monica Loi Monica Loi (= 1×) peers Gabriella Pagnan

Countries citing papers authored by Monica Loi

Since Specialization

Citations

This map shows the geographic impact of Monica Loi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Loi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Loi more than expected).

Fields of papers citing papers by Monica Loi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Loi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Loi. The network helps show where Monica Loi may publish in the future.

Co-authorship network of co-authors of Monica Loi

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Loi. A scholar is included among the top collaborators of Monica Loi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Loi. Monica Loi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keller, Christian W., Monica Loi, Laure‐Anne Ligeon, et al.. (2018). Endocytosis regulation by autophagy proteins in MHC restricted antigen presentation. Current Opinion in Immunology. 52. 68–73. 22 indexed citations

Keller, Christian W., Monica Loi, Isaak Quast, et al.. (2017). The autophagy machinery restrains iNKT cell activation through CD1D1 internalization. Autophagy. 13(6). 1025–1036. 28 indexed citations

Loi, Monica, Emanuela Olmetto, Isacco Desideri, et al.. (2017). BRCA1/2 mutation in breast cancer: biological aspects, patterns of care and impact on outcome in a monoinstitutional cohort. European Journal of Cancer. 72. S19–S19. 1 indexed citations

Loi, Monica, Anne Müller, Karin Steinbach, et al.. (2016). Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8+ T Cell Responses. Cell Reports. 15(5). 1076–1087. 126 indexed citations

Piaggio, Francesca, Vangelis Kondylis, Fabio Pastorino, et al.. (2015). A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects. Journal of Controlled Release. 223. 165–177. 89 indexed citations

Zuccari, Guendalina, Andrea Milelli, Fabio Pastorino, et al.. (2015). Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma. Journal of Controlled Release. 211. 44–52. 49 indexed citations

Loi, Monica, Pamela Becherini, Laura Emionite, et al.. (2014). sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib. Journal of Controlled Release. 192. 157–166. 25 indexed citations

Paolo, Daniela Di, Fabio Pastorino, Guendalina Zuccari, et al.. (2013). Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma. Journal of Controlled Release. 170(3). 445–451. 39 indexed citations

Paolo, Daniela Di, Chiara Ambrogio, Fabio Pastorino, et al.. (2011). Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma. Molecular Therapy. 19(12). 2201–2212. 52 indexed citations

10.

Loi, Monica, Daniela Di Paolo, Pamela Becherini, et al.. (2011). The use of the orthotopic model to validate antivascular therapies for cancer. The International Journal of Developmental Biology. 55(4-5). 547–555. 41 indexed citations

11.

Paolo, Daniela Di, Chiara Brignole, Fabio Pastorino, et al.. (2011). Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK. Molecular Therapy. 19(6). 1131–1140. 52 indexed citations

12.

Brignole, Chiara, Danilo Marimpietri, Daniela Di Paolo, et al.. (2010). Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma. Cancer Research. 70(23). 9816–9826. 60 indexed citations

13.

Loi, Monica, Serena Marchiò, Pamela Becherini, et al.. (2010). Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma. Journal of Controlled Release. 145(1). 66–73. 60 indexed citations

14.

Pagnan, Gabriella, Daniela Di Paolo, Roberta Carosio, et al.. (2009). The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response. Clinical Cancer Research. 15(4). 1199–1209. 38 indexed citations

15.

Brignole, Chiara, Danilo Marimpietri, Fabio Pastorino, et al.. (2009). Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides. Journal of Controlled Release. 138(2). 122–127. 10 indexed citations

16.

Paolo, Daniela Di, Monica Loi, Fabio Pastorino, et al.. (2009). Chapter 12 Liposome-Mediated Therapy of Neuroblastoma. Methods in enzymology on CD-ROM/Methods in enzymology. 465. 225–249. 10 indexed citations

17.

Pastorino, Fabio, Daniela Di Paolo, Federica Piccardi, et al.. (2008). Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin. Clinical Cancer Research. 14(22). 7320–7329. 74 indexed citations

18.

Paolo, Daniela Di, Fabio Pastorino, Chiara Brignole, et al.. (2008). Drug Delivery Systems: Application of Liposomal Anti-Tumor Agents to Neuroectodermal Cancer Treatment. Tumori Journal. 94(2). 246–253. 18 indexed citations

19.

Pisano, Marina, Gabriella Pagnan, Monica Loi, et al.. (2007). Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Molecular Cancer. 6(1). 8–8. 127 indexed citations

20.

Micheletti, R., Marcella Rocchetti, Achille Schiavone, et al.. (2002). Pharmacological Profile of the Novel Inotropic Agent (E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride (PST2744). Journal of Pharmacology and Experimental Therapeutics. 303(2). 592–600. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact